Dominique Salmon

ORCID: 0000-0003-1229-2429
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatitis C virus research
  • HIV Research and Treatment
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • Long-Term Effects of COVID-19
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Infectious Diseases and Tuberculosis
  • Tuberculosis Research and Epidemiology
  • Healthcare Systems and Practices
  • Mycobacterium research and diagnosis
  • Viral-associated cancers and disorders
  • HIV, Drug Use, Sexual Risk
  • COVID-19 Clinical Research Studies
  • Diagnosis and treatment of tuberculosis
  • Orthopedic Infections and Treatments
  • Cytomegalovirus and herpesvirus research
  • Pneumonia and Respiratory Infections
  • Peripheral Neuropathies and Disorders
  • Blood groups and transfusion
  • Antibiotics Pharmacokinetics and Efficacy
  • Systemic Lupus Erythematosus Research
  • Antimicrobial Resistance in Staphylococcus

Assistance Publique – Hôpitaux de Paris
2016-2025

Institut Alfred Fournier
2023-2025

Hôpital Cochin
2016-2025

Hôtel-Dieu de Paris
2012-2024

Université Paris Cité
2015-2024

Délégation Paris 5
2011-2024

Hotel Dieu Hospital
2020-2023

Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale
2009-2023

Inserm
1973-2022

Hôpital Bichat-Claude-Bernard
1988-2022

Human herpesvirus 8 (HHV-8, also called KSHV) is linked to the etiopathogenesis of Kaposi’s sarcoma (KS), multicentric Castleman’s disease (MCD), and primary effusion lymphoma (PEL). The universal presence HHV-8 in early KS has not yet been shown. We used a mAb (LN53) against latent nuclear antigen-1 (LNA-1) encoded by ORF73 study distribution cell types latently infected patch, plaque, nodular KS, MCD, PEL. In present <10% cells forming walls ectatic vessels. surrounding slit-like...

10.1073/pnas.96.8.4546 article EN Proceedings of the National Academy of Sciences 1999-04-13

Abstract Objective Tuberculosis (TB) is associated with anti–tumor necrosis factor (anti‐TNF) monoclonal antibody (mAb) therapy, but whether this association drug‐specific remains a concern. Our objective was to describe cases of TB anti‐TNF mAb identify risk factors, and estimate the incidence. Methods We conducted an incidence study case–control analysis investigate newly diagnosed use agents. As part French Research Axed on Tolerance Biotherapies (RATIO) registry, for 3 years we collected...

10.1002/art.24632 article EN Arthritis & Rheumatism 2009-06-29

10.1053/j.gastro.2016.09.009 article EN Gastroenterology 2016-09-16

Whereas recent investigations have revealed viral, inflammatory, and vascular factors involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lung pathogenesis, the pathophysiology of neurological disorders disease 2019 (COVID-19) remains poorly understood. Olfactory taste dysfunction are common COVID-19, especially mildly symptomatic patients. Here, we conducted a virologic, molecular, cellular study olfactory neuroepithelium seven patients with COVID-19 presenting loss...

10.1126/scitranslmed.abf8396 article EN cc-by Science Translational Medicine 2021-05-03

The multicenter national Mortalité 2005 survey aimed at describing the distribution of causes death among HIV-infected adults in France and its changes as compared with 2000.Physicians involved management HIV infection notified deaths documented using a standardized questionnaire similar to previous performed 2000.Overall, 1042 were (vs 964 2000): median age, 46 years 41 years); men, 76%; last CD4 cell count, 161/mm 94). proportion underlying due AIDS decreased (36% vs 47% 2000), cancer not...

10.1097/qai.0b013e31817efb54 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2008-08-15

The Mortalité 2010 survey aimed at describing the causes of death among HIV-infected patients in France and their evolution since 2000.A national sample clinical sites, providing HIV care treatment, notified documented deaths using a standardized questionnaire.The 90 participating wards 728 deaths. Median age was 50 years (interquartile range 45-58) 75% were men. main underlying AIDS-related (25% vs. 36% 2005 47% 2000), non-AIDS non-viral hepatitis-related malignancy (22 17 11%),...

10.1097/qad.0000000000000222 article EN AIDS 2014-02-12

Abstract BACKGROUND Before the introduction of highly active antiretroviral therapy (HAART), malignancies accounted for less than 10% all deaths among human immunodeficiency virus (HIV)‐infected patients. This figure may have increased, and observed types malignant disease been modified, as a result decreased occurrence opportunistic infections, chronicity HIV infection, possible oncogenic role itself, aging HIV‐infected population. METHODS All French hospital wards involved in management...

10.1002/cncr.20354 article EN Cancer 2004-06-14

Objective: To describe cases of lymphoma associated with anti-TNF therapy, identify risk factors, estimate the incidence and compare risks for different agents. Methods: A national prospective registry was designed (Research Axed on Tolerance bIOtherapies; RATIO) to collect all in French patients receiving therapy from 2004 2006, whatever indication. case–control analysis conducted including two controls treated per case an study population used as reference. Results: 38 lymphoma, 31...

10.1136/ard.2009.117762 article EN Annals of the Rheumatic Diseases 2009-10-14

The goal of the current study was to describe distribution and characteristics malignancy related deaths among human immunodeficiency virus (HIV)-infected patients with use data obtained from a national survey conducted in France 2005 compare results similar 2000.The underlying cause death documented using standardized questionnaire fulfilled French hospital wards networks that were involved treatment HIV-infected patients.Among 1042 reported (964 2000), 344 cancer (34%), which represented...

10.1086/596766 article EN Clinical Infectious Diseases 2009-01-29
Amanda Mocroft Hansjakob Furrer José M. Miró Peter Reiss Cristina Mussini and 95 more Ole Kirk Sophie Abgrall S. Ayayi Barbara Bartmeyer Dominique L. Braun Antonella Castagna Antonella d’Arminio Monforte Brian Gazzard Félix Gutiérrez Isabel Hurtado Klaus Jansen Laurence Meyer Pepa Muñoz Niels Obel Pere Soler‐Palacín Antonios Papadopoulos F. Raffi J. T. Ramos Jürgen K. Rockstroh Dominique Salmon Carlo Torti J. Warszawski Christoph Stephan Robert Zangerle Céline Fabre-Colin Jesper Kjær Geneviève Chêne Jesper Grarup Jens Lundgren Amanda Mocroft Hansjakob Furrer José M. Miró Peter Reiß Cristina Mussini Ole Kirk Sophie Abgrall S. Ayayi Barbara Bartmeyer Dominique L. Braun Antonella Castagna Antonella d’Arminio Monforte Brian Gazzard Félix Gutiérrez Isabel Hurtado Klaus Jansen Laurence Meyer Pepa Muñoz Niels Obel Pere Soler‐Palacín Antonios Papadopoulos François Raffi José Tomás Ramos Jürgen K. Rockstroh Dominique Salmon‐Céron Carlo Torti Josianne Warszawski Christoph Stephan Robert Zangerle Céline Fabre-Colin Jesper Kjær Geneviève Chêne Jesper Grarup Jens Lundgren Jens Lundgren Jose Miiro Pere Soler‐Palacín Carolo Torti Josiane Warszawski Jürgen K. Rockstroh José Manuel Ramos José M. Miró Pepa Muñoz Ali Judd Josiane Warszawski David Haerry Ian Weller Jordi Casabona Dominique Costagliola Antonella d’Arminio Monforte Manuel Battegay Maria Prins Frank de Wolf Céline Colin Christine Schwimmer Guillaume Touzeau Maria Campbell Julia Bohlius Vincent Bouteloup Heiner C. Bucher Alessandro Cozzi-Lepri François Dabis Maria Dorrucci Matthias Egger Frederik Neess Engsig Olivier Lambotte

Background. Few studies consider the incidence of individual AIDS-defining illnesses (ADIs) at higher CD4 counts, relevant on a population level for monitoring and resource allocation.

10.1093/cid/cit423 article EN Clinical Infectious Diseases 2013-08-06
Antoine Chéret Charline Bacchus-Souffan Véronique Avettand-Fènoël Adeline Mélard Georges Nembot and 95 more Catherine Blanc Assia Samri Asier Sáez‐Cirión Laurent Hocqueloux Caroline Lascoux‐Combe Clotilde Allavena Cécile Goujard Marc Antoine Valantin A. Leplatois Laurence Meyer Christine Rouzioux Brigitte Autran Bruno Hoën Christophe Bourdeaux Jean‐François Delfraissy Cécile Goujard I. Amri Erwan Fourn Yann Quertainmont M.Leonard Mole A. Rami A. Durel Myriam Diemer Maguy Parrinello Thierry Allègre Alain Lafeuillade Gilles Hittinger Véronique Lambry M. Carrerre G. Stevenson Philip Claudine Duvivier Paul‐Henri Consigny Caroline Charlier Maryam Shoai F. Touam G. Pialoux Laurence Slama Thomas L’Yavanc Philippe Mathurin Asma Adda V Berrebi Dominique Salmon E. Chakvetadze T. Tassadit E. Ousseima M.P. Pietri Yaniv Levy Anne Sophie Lascaux Jean‐Daniel Lelièvre M. Giovanna S. Dominguez Clément Dumont Christine Katlama M. A. Valentin Sophie Seang Lars Schneider N. Kiorza Aziza Chermak Saoussen Ben Abdallah Anne Simon F. Pichon Michèle Pauchard Jean‐Michel Molina C. Lascoux Diane Ponscarme Nathalie Verdière Anne Scemla N. De Castro A. Rachline Valérie Garrait W. Rozenbaum Samuel Ferret Suna Balkan F Clavel Mathieu Tourdjman Matthieu Lafaurie Alexandre Aslan Jérôme Goguel S. Thierry Victoire de Lastours S. Gallien J. Pavie Jonathan Delgado C. Mededji R. Verón Sylvie Abel S. Pierre-François C. Baringhton J.M. Chennebault Yves-Marie Vandamme P Fialaire Sami Rehaiem V. Rabier P. Abgueguen P. Morlat

Abstract Background Therapeutic control of HIV replication reduces the size viral reservoir, particularly among central memory CD4+ T cells, and this effect might be accentuated by early treatment. Methods We examined ART initiated at time primary infection (early ART), lasting 2 6 years in 11 10 patients, respectively, on reservoir peripheral resting sorted into naive (TN), (TCM), transitional (TTM) effector (TEM) comparison with post-treatment controllers (PTCs). Results Between baseline...

10.1093/jac/dkv084 article EN Journal of Antimicrobial Chemotherapy 2015-04-21
Rachel Sacks‐Davis Daniela K van Santen Anders Boyd Jim Young Ashleigh Stewart and 95 more Joseph Doyle Andri Rauch Catrina Mugglin Marina B. Klein Marc van der Valk Colette Smit Inmaculada Jarrín Juan Berenguer Karine Lacombe Maria-Bernarda Requena Linda Wittkop Olivier Leleux Fabrice Bonnet Dominique Salmon Gail Matthews Rebecca Guy Natasha K. Martin Tim Spelman Maria Prins Mark Stoové Margaret Hellard Margaret Hellard Rachel Sacks‐Davis Daniela K van Santen Ashleigh Stewart Tianhui Ke Zhang Yan-qin Mark Stoové Rebecca Guy Alisa Pedrana Jason Asselin Joshua Dawe Anna L. Wilkinson Anders Boyd Colette Smit Marc van der Valk Janke Schinkel Linda Wittkop Dominique Salmon‐Céron Philippe Sogni Laure Esterle Camille Gilbert Laurence Merchadou S. Gillet Coralie Khan Fabrice Bonnet Olivier Leleux Fabien Le Marec Adélaïde Perrier Gail Matthews Ineke Shaw Marianne Martinello Tanya Applegate Joanne Carson Joseph Doyle Brendan Harney Melissa B. Bryant Inmaculada Jarrín Juan Berenguer Belén Alejos Jeffrey V. Lazarus Cristina Moreno Rebecca Izquierdo Marta Rava Marina B. Klein Shouao Wang Jessica Lumia Costa Pexos Hansi Peiris Sahar Saeed Erica E. M. Moodie Jim Young Neora Pick Brian Conway Mark Hull Alex Wong M. John Gill Lisa Barrett Jeff Cohen Joseph Cox Pierre Côté Shariq Haider Danielle Rouleau Marie-Louise Vachon Anita Rachlis Roger Sandre Sharon Walmsley Aida Sadr Curtis Cooper Stephen Sanche Andri Rauch Catrina Mugglin Luisa Salazar-Viscaya Katharina Kusejko Maria Prins

10.1016/s2352-3018(23)00267-9 article EN The Lancet HIV 2024-01-21

ABSTRACT The ex vivo antiviral CD8 + repertoires of 34 human immunodeficiency virus (HIV)-seropositive patients with various CD4 T-cell counts and loads were analyzed by gamma interferon enzyme-linked immunospot assay, using peptides derived from HIV type 1 Epstein-Barr (EBV). Most recognized many peptides, markedly high frequencies, in association all the HLA class I molecules tested. We found no correlation between intensity anti-HIV responses or load. In contrast, polyclonality was...

10.1128/jvi.73.9.7108-7116.1999 article EN Journal of Virology 1999-09-01

To determine the correlates of immune recovery from active human CMV (HCMV) disease, we compared antigenic repertoire, diversity, magnitude, and differentiation HCMV-specific CD8+ T cells in HIV-HCMV coinfected subjects with no, cured, or HCMV disease healthy HIV-negative HCMV-positive controls. ELISPOT–IFN-γ assays using peptide pools spanning pp65 immediate early 1 (IE1) proteins showed that had a significantly broader repertoire greater diversity HIV-positive patients controlling...

10.1084/jem.20042408 article EN The Journal of Experimental Medicine 2005-06-20

Abstract Reactivation of latent Mycobacterium tuberculosis ( Mtb ) infection is a major complication anti-tumour necrosis factor (TNF)-α treatment, but its mechanism not fully understood. We evaluated the effect TNF antagonists infliximab (Ifx), adalimumab (Ada) and etanercept (Eta) on anti-mycobacterial immune responses in two conditions: with ex vivo studies from patients treated vitro addition to cells stimulated mycobacterial antigens. In both cases, we analysed response CD4 + T...

10.1186/ar1994 article EN cc-by Arthritis Research & Therapy 2006-07-19
Coming Soon ...